Earnings reports are critical events for investors as they provide insight into a company's financial health. When a company like Acumen Pharmaceuticals reports EPS results that are below market expectations, it often leads to a negative short-term reaction in its stock price. This is because investors may adjust their expectations for future profitability downwards, leading to a sell-off.